SCHEMBL3296160

SCHEMBL3296160

CCCCOc1ccccc1[SiH](O[SiH](c1ccccc1OCCCC)c1ccccc1OCCCC)c1ccccc1OCCCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.55
CYP2C9 P11712 2/20 0.55
CYP2C19 P33261 2/20 0.55
TLR8 Q9NR97 3/20 0.44
LTA4H P09960 2/20 0.43
CYP19A1 P11511 1/20 0.43
HIF1A Q16665 1/20 0.42
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
NR1I2 O75469 1/20 0.41
LMNA P02545 1/20 0.41
CHRM2 P08172 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADRA2A P08913 1/20 0.41
OPRK1 P41145 1/20 0.41
HTR2B P41595 1/20 0.41
SLC6A3 Q01959 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MCHR1 Q99705 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3294491 0.84 CYP1A2 (0.46) CYP1A2CYP2C9CYP2C19TLR8CYP19A1
SCHEMBL3297503 0.84 CYP1A2 (0.46) CYP1A2CYP2C9CYP2C19TLR8CYP19A1
SCHEMBL3297921 0.83 CYP1A2 (0.45) CYP1A2CYP2C9CYP2C19TLR8LTA4H
SCHEMBL3298061 0.82 ALDH1A1 (0.50) CYP1A2CYP2C19TLR8KMT2AMAPT
SCHEMBL3300356 0.80 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19TLR8LTA4H
SCHEMBL3295598 0.80 LTA4H (0.44) CYP1A2CYP2C9CYP2C19TLR8LTA4H
1,2-Dibutoxybenzene SCHEMBL1226749 0.80 CYP1A2 (0.72) CYP1A2CYP2C9CYP2C19TLR8LTA4H
1,2-Dibutoxybenzene SCHEMBL29428927 0.80 CYP1A2 (0.72) CYP1A2CYP2C9CYP2C19TLR8LTA4H
SCHEMBL3297756 0.79 CYP1A2 (0.52) CYP1A2CYP2C9CYP2C19TLR8LTA4H
SCHEMBL3295354 0.79 LTA4H (0.43) CYP1A2CYP2C9CYP2C19TLR8LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 CYP1A2 945/4885CYP2C9 1864/4885CYP2C19 1527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.